Abstract
Background: Edaravone, a free radical scavenger, is expected to play a neuro-protective role in amyotrophic lateral sclerosis (ALS), and it suppresses the decline of motor function in patients with ALS.
Full Text 
Sign-in/Register to access full text options
Sign-in/Register to access full text options 
Paper version not known
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
